Showing results (331-340 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|August 12, 2022
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancerMinwei Bao, Yuxia Huang, Zhongping Lang, et al.Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.Translational Lung Cancer Research|February 10, 2023
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort studyQi-Hua Zou, Hui Liu, Cai-Wen Huang, et al.Translational Lung Cancer Research|February 10, 2023
Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort studyGuangyin Zhao, Hongyu Zhang, Fengkai Xu, et al.Translational Lung Cancer Research|February 10, 2023
Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesionsAlexander J Allen, Dominic A Labella, Roman O Kowalchuk, et al.Translational Lung Cancer Research|February 10, 2023
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarkerSeohyun Kim, Jeong Uk Lim, Hye Seon Kang, et al.Translational Lung Cancer Research|February 10, 2023
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cellsJohan Vad-Nielsen, Nicklas Heine Staunstrup, Magnus Lindkvist Kjeldsen, et al.Translational Lung Cancer Research|February 10, 2023
BRAF RNA is prognostic and widely expressed in lung adenocarcinomaDavid Dora, Imre Vörös, Zoltán V Varga, et al.Translational Lung Cancer Research|February 10, 2023
Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer patientsChristoffer T Maansson, Sofie Helstrup, Eva B F Ebert, et al.Translational Lung Cancer Research|March 10, 2023
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative reviewGrace Chazan, Benjamin J SolomonPageof 240